Interview Series 20th February 2020
From the helm: CSL's David Lamont on the biotech giant's bright future
In the latest instalment of Bell Direct's From the helm series, Jess has a chat with CSL's CFO David Lamont.
David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL's own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.
Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL's future proofing strategy.